Long-term treatment with adalimumab in psoriatic arthritis: serum adalimumab concentration, immunogenicity and the link with clinical response

Conclusions
Serum adalimumab could be an important tool that may improve the management of psoriatic arthritis in patients responding to long-term treatment.

Source: Journal of International Medical Research - September 27, 2016 Category: Research Authors: Chimenti, M. S., Triggianese, P., Narcisi, A., Marinari, B., Teoli, M., Faleri, S., Arcese, A., Perricone, R., Costanzo, A. Tags: Immuno-Mediated Diseases and Treatment Immunogenicity Source Type: research